Skip to main content
. 2002 May;235(5):621–630. doi: 10.1097/00000658-200205000-00003

graphic file with name 3FF5.jpg

Figure 5. Gastrin-releasing peptide (GRP) treatment increases the growth of neuroblastoma cells. GRP treatment increases cell growth in all four (SK-N-SH, LAN-1, IMR-32, SH-SY5Y) neuroblastoma cell lines, when compared to control. Mean ± SEM for triplicate determination; *P < .05 vs. control.

HHS Vulnerability Disclosure